Sparfosic acid trisodium is a potent inhibitor of aspartate transcarbamoylase, exhibiting antitumor and antimetabolite activities; it induces apoptosis in resistant Br1 cells, causes S-phase cell cycle arrest, and activates apoptotic pathways leading to cell death.